K. H. Kim et al. / Tetrahedron Letters 51 (2010) 3368–3371
3371
Vomero, S.; Donati, A.; Casolaro, M.; Mendichi, R.; Giorgi, G.; Makovec, F. J. Org.
Chem. 2003, 68, 9473–9476; (f) Basurto, S.; Garcia, S.; Neo, A. G.; Torroba, T.;
Marcos, C. F.; Miguel, D.; Barbera, J.; Ros, M. B.; de la Fuente, M. R. Chem. Eur. J.
2005, 11, 5362–5376.
6.28 (d, J = 0.9 Hz, 1H), 7.07–7.13 (m, 1H), 7.25–7.35 (m, 6H), 7.54 (dd, J = 8.1
and 1.5 Hz, 1H), 7.69 (dd, J = 8.1 and 1.8 Hz, 1H); 13C NMR (CDCl3, 75 MHz) d
51.86, 52.61, 75.54, 126.86, 126.91, 127.20, 127.88, 128.26 (2C), 128.39,
129.91, 133.22, 138.15, 139.98, 141.73, 166.66. Anal. Calcd for C18H17BrO3: C,
59.85; H, 4.74. Found: C, 60.11; H, 4.98.
2. For the synthesis of fulvene derivatives and their applications to medicinal
chemistry, see: (a) Alcalde, E.; Mesquida, N.; Frigola, J.; Lopez-Perez, S.; Merce,
R. Org. Biomol. Chem. 2008, 6, 3795–3810; (b) Jeffrey, J. L.; Sarpong, R.
Tetrahedron Lett. 2009, 50, 1969–1972; A variety of benzofulvene derivatives
Compound 3g (anti): 69%; colorless oil; IR (film) 3448, 3063, 2223, 1471 cmÀ1 1H
;
NMR (CDCl3, 300 MHz) d 2.34 (br s, 1H), 4.60 (d, J = 9.0 Hz, 1H), 5.26 (d, J = 9.0 Hz,
1H), 6.04 (s, 1H), 6.10 (s, 1H), 7.03 (ddd, J = 9.3, 7.5 and 1.8 Hz, 1H), 7.16–7.31 (m,
6H), 7.42 (dd, J = 8.1 and 1.2 Hz, 1H), 7.60 (dd, J = 7.8 and 1.5 Hz, 1H); 13C NMR
(CDCl3, 75 MHz) d 55.00, 75.18, 117.99, 122.86, 124.79, 126.80, 127.80, 128.28,
128.39, 128.98, 129.14, 133.22, 133.75, 136.81, 140.57. Anal. Calcd for
C17H14BrNO: C, 62.21; H, 4.30; N, 4.27. Found: C, 62.56; H, 4.67; N, 4.13.
Typical synthetic procedure of 4a: A solution of 3a (361 mg, 1.0 mmol), acetic
anhydride (153 mg, 1.5 mmol), pyridine (158 mg, 2.0 mmol), and DMAP
(12 mg, 0.1 mmol) in CH2Cl2 (4 mL) was stirred at room temperature for 1 h.
After the usual aqueous extractive workup and column chromatographic
purification process (hexanes/EtOAc, 15:1) compound 4a was obtained as
colorless oil, 383 mg (95%). Other compounds 4b–h were prepared similarly
and the selected spectroscopic data of 4a and 4g are as follows.
has been developed as
a nonsteroidal anti-inflammatory drug (NSAID)
including sulindac and sulindac sulfone. These compounds were generally
prepared via the Knoevenagel condensation between aldehydes and indene
derivatives, see: (c) Walters, M. J.; Blobaum, A. L.; Kingsley, P. J.; Felts, A. S.;
Sulikowski, G. A.; Marnett, L. J. Bioorg. Med. Chem. Lett. 2009, 19, 3271–3274; (d)
Felts, A. S.; Siegel, B. S.; Young, S. M.; Moth, C. W.; Lybrand, T. P.; Dannenberg, A.
J.; Marnett, L. J.; Subbaramaiah, K. J. Med. Chem. 2008, 51, 4911–4919.
3. For the synthesis of fulvene derivatives, see: (a) Vavilala, C.; Byrne, N.; Kraml, C.
M.; Ho, D. M.; Pascal, R. A., Jr. J. Am. Chem. Soc. 2008, 130, 13549–13551; (b)
Peabody, S. W.; Breiner, B.; Kovalenko, S. V.; Patil, S.; Alabugin, I. V. Org. Biomol.
Chem. 2005, 3, 218–221; (c) Kovalenko, S. V.; Peabody, S.; Manoharan, M.;
Clark, R. J.; Alabugin, I. V. Org. Lett. 2004, 6, 2457–2460; (d) Bucher, G.;
Mahajan, A. A.; Schmittel, M. J. Org. Chem. 2008, 73, 8815–8828; (e) Watanabe,
M.; Shiine, K.; Ideta, K.; Matsumoto, T.; Thiemann, T. J. Chem. Res. 2008, 669–
678; (f) Lu, J.-M.; Zhu, Z.-B.; Shi, M. Chem. Eur. J. 2009, 15, 963–971; (g) Li, C.;
Zeng, Y.; Wang, J. Tetrahedron Lett. 2009, 50, 2956–2959; (h) Cordier, P.; Aubert,
C.; Malacria, M.; Lacote, E.; Gandon, V. Angew. Chem., Int. Ed. 2009, 48, 8757–
8760; (i) Schmittel, M.; Vavilala, C. J. Org. Chem. 2005, 70, 4865–4868.
4. For the other synthesis of fulvene derivatives, see: (a) Furuta, T.; Asakawa, T.;
Iinuma, M.; Fujii, S.; Tanaka, K.; Kan, T. Chem. Commun. 2006, 3648–3650; (b)
Dyker, G.; Borowski, S.; Henkel, G.; Kellner, A.; Dix, I.; Jones, P. G. Tetrahedron Lett.
2000, 41, 8259–8262; (c) Lee, C.-Y.; Wu, M.-J. Eur. J. Org. Chem. 2007, 3463–3467;
(d) Ye, S.; Yang, X.; Wu, J. Chem. Commun. 2010, 2950–2952; (e) Ye, S.; Gao, K.;
Zhou, H.; Yang, X.; Wu, J. Chem. Commun. 2009, 5406–5408; (f) Rahman, S. M. A.;
Sonoda, M.; Itahashi, K.; Tobe, Y. Org. Lett. 2003, 5, 3411–3414.
5. For the general review on Baylis–Hillman reaction, see: (a) Basavaiah, D.; Rao,
A. J.; Satyanarayana, T. Chem. Rev. 2003, 103, 811–891; (b) Singh, V.; Batra, S.
Tetrahedron 2008, 64, 4511–4574; (c) Ciganek, E.. In Organic Reactions;
Paquette, L. A., Ed.; John Wiley & Sons: New York, 1997; Vol. 51, pp 201–
350; (d) Basavaiah, D.; Rao, P. D.; Hyma, R. S. Tetrahedron 1996, 52, 8001–8062;
(e) Drewes, S. E.; Roos, G. H. P. Tetrahedron 1988, 44, 4653–4670; (f) Kim, J. N.;
Lee, K. Y. Curr. Org. Chem. 2002, 6, 627–645; (g) Lee, K. Y.; Gowrisankar, S.; Kim,
J. N. Bull. Korean Chem. Soc. 2005, 26, 1481–1490; (h) Langer, P. Angew. Chem.,
Int. Ed. 2000, 39, 3049–3052; (i) Radha Krishna, P.; Sachwani, R.; Reddy, P. S.
Synlett 2008, 2897–2912; (j) Declerck, V.; Martinez, J.; Lamaty, F. Chem. Rev.
2009, 109, 1–48.
Compound 4a (syn): 95%; colorless oil; IR (film) 2951, 1735, 1724, 1232 cmÀ1
;
1H NMR (CDCl3, 300 MHz) d 1.83 (s, 3H), 3.58 (s, 3H), 5.13 (d, J = 9.9 Hz, 1H),
5.63 (s, 1H), 6.28 (s, 1H), 6.41 (d, J = 9.9 Hz, 1H), 7.06–7.12 (m, 1H), 7.24–7.34
(m, 4H), 7.38–7.42 (m, 2H), 7.51 (dd, J = 7.8 and 1.5 Hz, 1H), 7.56 (dd, J = 8.1
and 1.2 Hz, 1H); 13C NMR (CDCl3, 75 MHz) d 20.81, 50.15, 51.93, 76.28, 126.46,
127.26, 127.71, 128.29, 128.35, 128.37, 128.43, 129.30, 133.06, 138.15, 138.25,
138.96, 166.28, 169.78.
Compound 4g (anti): 91%; pale yellow solid; mp 99–101 °C; IR (film) 3063,
3034, 2223, 1743, 1226 cmÀ1 1H NMR (CDCl3, 300 MHz) d 2.10 (s, 3H), 4.79 (d,
;
J = 9.9 Hz, 1H), 6.00 (d, J = 0.9 Hz, 1H), 6.04 (s, 1H), 6.30 (d, J = 9.9 Hz, 1H), 7.04
(ddd, J = 7.5, 7.5 and 1.8 Hz, 1H), 7.16–7.31 (m, 6H), 7.44 (dd, J = 8.1 and 1.2 Hz,
1H), 7.52 (dd, J = 8.1 and 1.8 Hz, 1H); 13C NMR (CDCl3, 75 MHz) d 20.97, 52.86,
75.79, 117.62, 122.40, 124.95, 127.41, 127.85, 128.33, 128.50, 129.26, 129.30,
133.33, 133.67, 135.61, 136.94, 169.59; ESIMS m/z 392 [M+Na]+, 394
[M+2+Na]+.
Typical synthetic procedure of 6a (condition C): A stirred solution of 4a (202 mg,
0.5 mmol), Pd(OAc)2 (11 mg, 0.05 mmol), PPh3 (26 mg, 0.1 mmol), and TEA
(101 mg, 1.0 mmol) in CH3CN (4 mL) was heated to reflux for 1 h under
nitrogen atmosphere. The reaction mixture was allowed to cool to room
temperature, the reaction was quenched with water (10 mL), and the reaction
mixture was extracted with diethyl ether (30 mL Â 3). The combined organic
layers were washed with dilute HCl solution, brine, dried over MgSO4, and
concentrated under vacuum. The residue was purified by column
chromatography (hexanes/EtOAc, 20:1) to afford compounds 6a-E (111 mg,
85%), and 6a-Z (13 mg, 10%). Other compounds 6b–h were prepared similarly
and the selected spectroscopic data of compounds 6a, 6e, and 6g are as follows.
Compound 6a-E: 85%; pale yellow solid; mp 35–36 °C; IR (film) 3056, 2948,
6. For the Pd-catalyzed chemical transformations of Baylis–Hillman adducts, see:
(a) Gowrisankar, S.; Lee, H. S.; Kim, S. H.; Lee, K. Y.; Kim, J. N. Tetrahedron 2009,
65, 8769–8780. and further references cited therein; (b) Kim, K. H.; Kim, E. S.;
Kim, J. N. Tetrahedron Lett. 2009, 50, 5322–5325; (c) Kim, H. S.; Lee, H. S.; Kim, S.
H.; Kim, J. N. Tetrahedron Lett. 2009, 50, 3154–3157; (d) Kim, J. M.; Kim, S. H.;
Lee, H. S.; Kim, J. N. Tetrahedron Lett. 2009, 50, 1734–1737; (e) Park, J. B.; Ko, S.
H.; Hong, W. P.; Lee, K.-J. Bull. Korean Chem. Soc. 2004, 25, 927–930; (f)
Vasudevan, A.; Tseng, P.-S.; Djuric, S. W. Tetrahedron Lett. 2006, 47, 8591–8593;
(g) Kim, J. M.; Kim, K. H.; Kim, T. H.; Kim, J. N. Tetrahedron Lett. 2008, 49, 3248–
3251. and further references cited therein.
1710, 1349, 1182 cmÀ1 1H NMR (CDCl3, 300 MHz) d 3.88 (s, 3H), 7.06 (t,
;
J = 8.1 Hz, 1H), 7.23 (t, J = 7.5 Hz, 1H), 7.36–7.47 (m, 5H), 7.52–7.55 (m, 2H),
7.72 (s, 1H), 8.48 (s, 1H); 13C NMR (CDCl3, 75 MHz) d 46.74, 118.43, 119.07,
122.93, 123.31, 123.67, 123.73, 124.43, 125.17, 131.66, 132.15, 132.31, 133.40,
135.65, 135.78, 160.36; ESIMS m/z 285 [M+Na]+. Anal. Calcd for C18H14O2: C,
82.42; H, 5.38. Found: C, 82.33; H, 5.64.
Compound 6a-Z: 10%; pale yellow oil; IR (film) 2945, 1716, 1431, 1244 cmÀ1
;
1H NMR (CDCl3, 300 MHz) d 3.25 (s, 3H), 7.28–7.45 (m, 8H), 7.60 (d, J = 0.9 Hz,
1H), 7.72–7.75 (m, 1H), 7.82 (d, J = 1.2 Hz, 1H); 13C NMR (CDCl3, 75 MHz) d
51.54, 119.84, 123.03, 127.68, 128.20, 128.43, 128.62, 130.42, 131.75, 132.47,
136.70, 137.62, 139.00, 139.16, 141.72, 167.01; ESIMS m/z 285 (M++Na).
7. Kim, K. H.; Lee, H. S.; Kim, S. H.; Kim, S. H.; Kim, J. N. Chem. Eur. J. 2010, 16,
2375–2380.
8. For the synthesis of cinnamyl bromide derivatives in a stereoselective manner
from Baylis–Hillman adducts, see: (a) Gowrisankar, S.; Kim, S. H.; Kim, J. N. Bull.
Korean Chem. Soc. 2009, 30, 726–728. and further references cited therein; (b)
Basavaiah, D.; Reddy, K. R.; Kumaragurubaran, N. Nat. Prot. 2007, 2, 2665–2676;
(c) Das, B.; Banerjee, J.; Ravindranath, N. Tetrahedron 2004, 60, 8357–8361; (d)
Fernandes, L.; Bortoluzzi, A. J.; Sa, M. M. Tetrahedron 2004, 60, 9983–9989; (e)
Sa, M. M.; Ramos, M. D.; Fernandes, L. Tetrahedron 2006, 62, 11652–11656; (f)
Deng, J.; Hu, X.-P.; Huang, J.-D.; Yu, S.-B.; Wang, D.-Y.; Duan, Z.-C.; Zheng, Z. J.
Org. Chem. 2008, 73, 2015–2017; (g) Lee, K. Y.; Lee, Y. J.; Kim, J. N. Bull. Korean
Chem. Soc. 2007, 28, 143–146; (h) Lee, K. Y.; Park, D. Y.; Kim, J. N. Bull. Korean
Chem. Soc. 2006, 27, 1489–1492.
9. For the stereoselective synthesis of Barbier reaction products, see: (a) Kim, K.
H.; Lee, H. S.; Kim, S. H.; Lee, K. Y.; Lee, J.-E.; Kim, J. N. Bull. Korean Chem. Soc.
2009, 30, 1012–1020. and further references cited therein; (b) Paquette, L. A.;
Mendez-Andino, J. Tetrahedron Lett. 1999, 40, 4301–4304; (c) Lee, A. S.-Y.;
Chang, Y.-T.; Wang, S.-H.; Chu, S.-F. Tetrahedron Lett. 2002, 43, 8489–8492; (d)
Kabalka, G. W.; Venkataiah, B.; Chen, C. Tetrahedron Lett. 2006, 47, 4187–4189;
(e) Yu, S. H.; Ferguson, M. J.; McDonald, R.; Hall, D. G. J. Am. Chem. Soc. 2005,
127, 12808–12809.
Compound 6e-E: 57%; colorless oil; IR (film) 2949, 1710, 1362, 1184 cmÀ1 1H
;
NMR (CDCl3, 300 MHz) d 2.41 (d, J = 7.5 Hz, 3H), 3.84 (s, 3H), 7.26–7.39 (m, 2H),
7.44–7.47 (m, 1H), 7.61–7.68 (m, 2H), 7.82 (d, J = 7.5 Hz, 1H); 13C NMR (CDCl3,
75 MHz) d 16.21, 51.35, 123.29, 124.40, 127.31, 127.75, 129.59, 136.79, 137.23,
137.55, 138.66, 140.16, 165.19; ESIMS m/z 223 (M++Na). Anal. Calcd for
C13H12O2: C, 77.98; H, 6.04. Found: C, 78.23; H, 6.25.
Compound 6g-E: 36%; pale yellow oil; IR (film) 3054, 2919, 2215, 1447 cmÀ1
;
1H NMR (CDCl3, 300 MHz) d 7.18 (ddd, J = 7.5, 7.5 and 1.2 Hz, 1H), 7.31 (ddd,
J = 7.5, 7.5 and 0.9 Hz, 1H), 7.42–7.53 (m, 5H), 7.58–7.67 (m, 4H); 13C NMR
(CDCl3, 75 MHz) d 113.22, 115.57, 123.24, 123.56, 128.29, 128.68, 128.95,
129.42, 129.47, 133.83, 135.01, 136.73, 137.68, 141.00, 141.74; ESIMS m/z 252
(M++Na). Anal. Calcd for C17H11N: C, 89.06; H, 4.84; N, 6.11. Found: C, 88.94; H,
4.97; N, 6.02.
Compound 6g-Z: 27%; pale yellow oil; IR (film) 3058, 2217, 1443 cmÀ1 1H NMR
;
(CDCl3, 300 MHz) d 7.35–7.51 (m, 6H), 7.58–7.62 (m, 2H), 7.74–7.77 (m, 2H),
7.91 (s, 1H); 13C NMR (CDCl3, 75 MHz) d 108.01, 116.71, 119.72, 122.93, 128.24,
128.45, 128.59, 129.82, 130.88, 133.70, 133.89, 135.74, 137.49, 138.22, 147.94;
ESIMS m/z 252 (M++Na).
10. Typical synthetic procedure of 3a: To a stirred solution of cinnamyl bromide 1a
(668 mg, 2.0 mmol)7,8 and benzaldehyde (2a, 233 mg, 2.2 mmol) in aqueous
THF (1:1, 4 mL) was added indium powder (250 mg, 2.2 mmol) and stirred at
room temperature for 1 h. After the usual aqueous extractive workup and
column chromatographic purification process (hexanes/EtOAc/CH2Cl2, 15:1:1)
compound 3a (syn) was obtained as colorless oil, 664 mg (92%). Other
compounds 3b–h were prepared similarly, and the selected spectroscopic
data of 3a and 3g are as follows.
11. For the similar Pd-catalyzed 1,4-elimination, see: (a) Tsuji, J.; Yamakawa, T.;
Kaito, M.; Mandai, T. Tetrahedron Lett. 1978, 19, 2075–2078; (b) Takacs, J. M.;
Lawson, E. C.; Clement, F. J. Am. Chem. Soc. 1997, 119, 5956–5957. and further
references cited therein; (c) Shimizu, I.; Matsumoto, Y.; Shoji, K.; Ono, T.;
Satake, A.; Yamamoto, A. Tetrahedron Lett. 1996, 37, 7115–7118; (d) Mikami,
K.; Ohmura, H. Org. Lett. 2002, 4, 3355–3357.
12. For the photoisomerization of similar compounds, see: (a) Barr, J. W.; Bell, T.
W.; Catalano, V. J.; Cline, J. I.; Phillips, D. J.; Procupez, R. J. Phys. Chem. A 2005,
109, 11650–11654; (b) Abdur Rahman, S. M.; Sonoda, M.; Ono, M.; Miki, K.;
Tobe, Y. Org. Lett. 2006, 8, 1197–1200.
Compound 3a (syn): 92%; colorless oil; IR (film) 3479, 2949, 1716, 1437,
1144 cmÀ1 1H NMR (CDCl3, 300 MHz) d 2.03 (d, J = 3.6 Hz, 1H), 3.57 (s, 3H),
;
4.86 (d, J = 7.8 Hz, 1H), 5.33 (dd, J = 7.8 and 3.6 Hz, 1H), 5.71 (t, J = 0.9 Hz, 1H),